Results 21 to 30 of about 697,296 (219)

Inflammatory bowel disease-specific autoantibodies in HLA-B27-associated spondyloarthropathies: Increased prevalence of ASCA and pANCA [PDF]

open access: yes, 2004
Aims: An association between inflammatory bowel disease (IBD) and spondyloarthropathies (SpA) has repeatedly been reported. The aim of the present study was to investigate whether serologic markers of IBD, e. g.
Folwaczny, Christian   +15 more
core   +1 more source

Acute tubulointerstitial nephritis associated with antineutrophil cytoplasmic antibody following cimetidine treatment: a case report

open access: yesBMC Nephrology, 2021
Background Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis usually induces rapidly progressive glomerulonephritis, including pauci-immune necrotizing crescentic glomerulonephritis.
Keita Morimoto   +7 more
doaj   +1 more source

Hydralazine-induced antineutrophil cytoplasmic antibody-associated vasculitis with pulmonary–renal syndrome: a case report

open access: yesJournal of Medical Case Reports, 2020
Background Hydralazine is a common vasodilator which has been used for the treatment of hypertension and heart failure. Hydralazine can induce antineutrophil cytoplasmic antibody-associated vasculitis due to its auto-immunogenic capability and one of the
Ahmad Al-Abdouh   +4 more
doaj   +1 more source

Antineutrophil cytoplasmic antibodies

open access: yesReumatismo, 2011
Antineutrophil cytoplasmic antibodies (ANCA) are predominantly IgG autoantibodies directed against constituents of primary granules of neutrophils and monocytes lysosomes. Although several antigenic targets have been identified, those ANCA directed to proteinase 3 or myeloperoxidase are clinically relevant, whereas the importance of other ANCA remains ...
openaire   +5 more sources

Antineutrophil cytoplasmic antibodies (ANCA)

open access: yesAutoimmunity, 2005
Antineutrophil cytoplasmic antibodies (ANCA) are a sensitive and specific marker for ANCA-associated systemic vasculitis. Using indirect immunofluorescence on ethanol-fixed neutrophils, two major fluoroscopic patterns can be recognised: a diffuse cytoplasmic staining (C-ANCA), and a perinuclear/nuclear staining (P-ANCA).
Radice, A, SINICO, RENATO ALBERTO
openaire   +2 more sources

Antineutrophil cytoplasmic antibodies: reporting and diagnostic strategies [PDF]

open access: yesAnnals of the Rheumatic Diseases, 2017
It was with great interest that we read the correspondence of Mahler and Fritzler1 on our recent European Vasculitis Study Group (EUVAS) study describing the performance of immunoassays for antineutrophil cytoplasmic antibodies (ANCA) in patients with ANCA-associated vasculitides (AAV).2 In their letter, Mahler and Fritzler raise some interesting ...
Damoiseaux, Jan   +4 more
openaire   +3 more sources

Proteinase 3-antineutrophil cytoplasmic antibody-positive necrotizing crescentic glomerulonephritis complicated by infectious endocarditis: a case report

open access: yesJournal of Medical Case Reports, 2019
Background Proteinase 3-antineutrophil cytoplasmic antibody has been reported to be positive in 5–10% of cases of renal injury complicated by infective endocarditis; however, histological findings have rarely been reported for these cases.
Katsunori Yanai   +15 more
doaj   +1 more source

Antineutrophil Cytoplasmic Antibodies and Infection

open access: yesAutoimmunity, 1993
(1993). Antineutrophil Cytoplasmic Antibodies and Infection. Autoimmunity: Vol. 15, No. 1, pp. 81-83.
J M, Durand   +7 more
openaire   +2 more sources

Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Update: Genetic Pathogenesis

open access: yesFrontiers in Immunology, 2021
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is characterized by the inflammation of small and medium vessels and presence of proteinase 3-ANCA or myeloperoxidase-ANCA in the circulation.
Weiran Li   +9 more
doaj   +1 more source

Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis [PDF]

open access: yes, 2015
Rituximab has been used in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) since 2003. Our objective was to describe outcomes and adverse events following rituximab since that time in an inception ...
Hu, Yichun   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy